The 65th Annual General Assembly and Scientific Meeting of the Japan College of Rheumatology

English Session

Symposium (Held onsite, Live streaming and On demand)

S1

Recent Perspectives on Treatments of Systemic Lupus Erythematosus

Monday, April 26   9:55 - 12:25  1F   Room 1 (Portpia Hall)

Chairs:

Yoshiya Tanaka

The First Department of Internal Medicine, University of Occupational and Environmental Health, Japan

 

Kenji Oku

Department of Rheumatology, Endocrinology and Nephrology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Japan

S1-1
Type I Interferon Targeting in SLE
 

Eric F. Morand

School of Clinical Sciences at Monash Health, Monash University Faculty of Medicine, Nursing & Health Sciences, Australia

S1-2
Role of IL-12 and IL-23 in the pathophysiology of systemic lupus erythematosus and their utility as therapeutic targets
 

Hajime Yoshifuji

Department of Rheumatology and Clinical Immunology, Graduate School of Medicine, Kyoto University, Japan

S1-3
Type I and type II anti-CD20
 

Hiroaki Niiro

Department of Medical Education, Faculty of Medical Sciences, Kyushu University, Japan

S1-4
Targeting the JAK in the treatment of SLE
 

Shingo Nakayamada

The First Department of Internal Medicine, University of Occupational and Environmental Health, Japan

S1-5
Efficacy of Low-Dose Interleukin-2 for Primary Sjögren's Syndrome–A Randomized Double-blind, Placebo-controlled Clinical Trial
 

Jing He

Peking University People's Hospital, China

S4

Evolution of Surgery for Rheumatoid Arthritis in Biologic and JAK Inhibitor Era—From the Past to the Future—

Monday, April 26   9:55 - 12:25  1F   Room 4 (Ohwada-C)

Chairs:

Jochem Nagels

Leiden University Medical Center, Leiden, The Netherlands

 

Yuho Kadono

Department of Orthopaedic Surgery, Saitama Medical University, Japan

S4-1
Current topics of shoulder joint in RA patients
Speaker:

Jochem Nagels

Leiden University Medical Center, Leiden, The Netherlands

S4-2
Evolution of elbow surgery for rheumatoid arthritis in biologic and JAK inhibitor era
Speaker:

Jun Hirose

Orthopaedics, JCHO Tokyo Shinjuku Medical Center, Japan

S4-3
Rheumatoid hand surgery today
Speaker:

Massimo Ceruso

Department of Orthopedics, Azienda Ospedaliero Universitaria Careggi, Italy

S4-4
Progress in surgery for forefoot deformities in patients with rheumatoid arthritis
Speaker:

Jun-ichi Fukushi

Department of Orthopaedic Surgery and Rheumatology, National Hospital Organization Kyushu Medical Center, Japan

S4-5
Evolution of the treatment for osteoporosis associated with rheumatic diseases
Speaker:

Kosuke Ebina

Department of Musculoskeletal Regenerative Medicine, Osaka University Graduate School of Medicine, Japan

S8

Treatment strategy of systemic rheumatic diseases―Lessons from clinical trials

Monday, April 26   13:45 - 16:15   1F   Room 4 (Ohwada-C)

Chairs:

Masataka Kuwana

Department of Allergy and Rheumatology, Nippon Medical School Graduate School of Medicine, Japan

 

Atsushi Kawakami

Department of Immunology and Rheumatology, Division of Advanced Preventive Medical Sciences, Nagasaki University Graduate School of Biomedical Sciences, Japan

S8-1
Systemic lupus erythematosus (SLE)
Speaker:

Yoshiya Tanaka

The First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Japan

S8-2
Management of Systemic Sclerosis-Associated Lung Fibrosis—Perspective from a US Scleroderma Center
Speaker:

Dinesh Khanna

University of Michigan, Michigan, USA

S8-3
Lessons Learned from Myositis Clinical Trials
Speaker:

Chester V. Oddis

University of Pittsburg School of Medicine, Pennsylvania, USA

S8-4
Treatment strategies in axial spondyloarthritis
Speaker:

Denis Poddubnyy

Charité Universitätsmedizin Berlin, Campus Benjamin Franklin Berlin, Germany

S8-5
Translational research to clinical trial in FMF
Speaker:

Atsushi Kawakami

Department of Immunology and Rheumatology, Division of Advanced Preventive Medical Sciences, Nagasaki University Graduate School of Biomedical Sciences, Japan

S9

Triangular Relationship in Arthritis—Immune Cells, Synovial Fibroblasts and Bone—

Monday, April 26   13:45 - 15:45  B1F   Room 5 (Kairaku-1)

Chairs:

Hiroshi Takayanagi

Department of Immunology, Graduate School of Medicine and Faculty of Medicine, The University of Tokyo, Japan

 

Keishi Fujio

Department of Allergy and Rheumatology, Graduate School of Medicine, The University of Tokyo, Japan

S9-1
Transcriptomic and epigenomic features of synovial fibroblasts in RA
 

Keishi Fujio

Department of Allergy and Rheumatology, Graduate School of Medicine, The University of Tokyo, Japan

S9-2
Identification of a novel arthritis-associated osteoclast precursor macrophage
 

Masaru Ishii

Department of Immunology and Cell Biology, Osaka University Graduate School of Medicine, Japan

S9-3
Functional genomics of immune cells and fibroblasts
 

Soumya Raychaudhuri

Harvard Medical School, Brigham and Women's Hospital, Broad Institute, USA

S9-4
Local priming of joints for susceptibility to arthritis
 

Georg Schett

Friedrich-Alexander University Erlangen-Nürnberg, Germany

S9-5
Osteoimmune interactions in arthritis
 

Hiroshi Takayanagi

Department of Immunology, Graduate School of Medicine and Faculty of Medicine, The University of Tokyo, Japan

S10

Latest Update in Treatment of Rheumatoid Arthritis

Tuesday, April 27   8:00 - 10:30   1F   Room 1 (Portpia Hall)

Chairs:

Kunihiro Yamaoka

Department of Rheumatology and Infectious Diseases, Kitasato University School of Medicine, Japan

 

Yoshiya Tanaka

The First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Japan

S10-1
Management of Rheumatoid Arthritis in the 21st Century: Lessons Learned and Problems Encountered
 

Allan Gibofsky

Weill Cornell Medical College and Hospital for Special Surgery, USA

S10-2
Message from post-marketing surveillance subcommittee of Japan Colleague of Rheumatology
 

Michiaki Takagi

Department of Orthopaedic Surgery, Yamagata University Faculty of Medicine, Japan

S10-3
New molecule therapeutics for rheumatoid arthritis
 

Roy M. Fleischmann

University of Texas Southwestern Medical Center at Dallas, Dallas, Texas, USA / Metroplex Clinical Research Center, USA

S10-4
Drug discovery through genomic analysis
 

Yukinori Okada

Department of Statistical Genetics, Osaka University Graduate School of Medicine, Japan

S10-5
Progress in established therapies
 

Arthur Kavanaugh

Division of Rheumatology, Allergy, Immunology, Department of Medicine, University of California, San Diego, USA

S22

Advances in research on human systemic autoimmune diseases

Wednesday, April 28   14:00 - 16:30   B1F   Room 5 (Kairaku-1)

Chairs:

Sachiko Miyake

Department of Immunology, Juntendo University, Japan

 

Keishi Fujio

Department of Allergy and Rheumatology, Graduate School of Medicine, The University of Tokyo, Japan

S22-1
How single cell studies and AMP are changing understanding of adaptive immunity in RA
Speaker:

Michael B. Brenner

Harvard Medical School, USA

S22-2
Pathways of B cell Activation in Human SLE
Speaker:

Iñaki Sanz

Department of Medicine, Division of Rheumatology, Lowance Center for Human Immunology, Emory University School of Medicine, Atlanta, GA, USA

S22-3
The MHC and SLE: have we finally solved it?
Speaker:

Timothy J Vyse

King's College London, UK

S22-4
Functional genome analysis of autoimmune diseases
Speaker:

Keishi Fujio

Department of Allergy and Rheumatology, Graduate School of Medicine, The University of Tokyo, Japan

Special Symposium (Held onsite, Live streaming and On demand)

SS1 (EULAR Session)

"EULAR recommends"—addressing clinical challenges in 2021?

Tuesday, April 27   8:00 - 10:00   B1F   Room 5 (Kairaku-1)

Chairs:

Annamaria Iagnocco

Dipartimento Scienze Clichie e Biologiche, Università degli Studi di Torino, Italy

 

Tsutomu Takeuchi

Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Japan

 

Atsushi Kawakami

Department of Immunology and Rheumatology, Division of Advanced Preventive Medical Sciences, Nagasaki University Graduate School of Biomedical Sciences, Japan

SS1-1
Managing difficult to treat RA in the real world
 

Johannes W. J. Bijlsma

Department of Rheumatology and Clinical Immunology, University Medical Center Utrecht, The Netherlands

SS1-2
Challenges in PsA - the EULAR updated view?
 

Daniel Aletaha

Division of Rheumatology, Medical University Vienna, Austria

SS1-3
When treating malignancy becomes a rheumatologic problem (Checkpoint inhibitors)
 

Iain B McInnes

University of Glasgow, UK

SS2 (ACR Session)

Animal models and computational biology to define mechanisms of arthritis pain and inflammation

Tuesday, April 27   14:15 - 16:15   B1F   Room 5 (Kairaku-1)

Chairs:

Yoshiya Tanaka

The First Department of Internal Medicine, School of Medicine, University of Occupational & Environmental Health, Japan

 

Kazuhiko Yamamoto

RIKEN Center for Integrative Medical Sciences, Japan

SS2-1
Using genetics and genomics to define molecular mechanisms for rheumatoid arthritis
 

Soumya Raychaudhuri

Center for Data Sciences, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA

SS2-2
Mechanisms underlying joint damage and pain in osteoarthritis reveal new targets
 

Anne-Marie Malfait

Division of Rheumatology, Rush University Medical Center, Chicago IL, USA

Meet the Expert (Live streaming) *Reservation Required

MTE7

Remission in RA

Monday, April 26   13:50 - 14:50

Lecturer:

Paul Emery

Leeds Institute Rheumatic and Musculoskeletal Medicine, University of Leeds, UK / Leeds NIHR Biomedical Research Centre, UK / The Leeds Teaching Hospitals Trust, Leeds, UK

Assistant:

Hideto Kameda

Division of Rheumatology, Department of Internal Medicine, Faculty of Medicine, Toho University, Japan

Reservation Period 17:00, March 1 (Mon), 2021 - 17:00, March 15 (Mon)
Reservation Period has been extended until Friday, April 16, 2021, 17:00 (JST).
*
If you would like to participate, please contact JCR 2021 registration desk (jcr2021-reg@congre.co.jp).

Sponsored Seminars (Held onsite, Live streaming)

MS3

Innovative strategies for the treatment of patients with rheumatoid arthritis

Monday, April 26   8:40 - 9:40   1F   Room 4 (Ohwada-C)

Chair:

Tsutomu Takeuchi

Department of Internal Medicine, Division of Rheumatology, Keio University School of Medicine, Japan

Speaker:

Arthur Kavanaugh

Rheumatology, Allergy, Immunology Division, University of California, San Diego, USA

Sponsor:
Gilead Sciences K.K. / Eisai Co., Ltd.

MS15

Staying at the cutting-edge: Latest update of Upadacitinib

Wednesday, April 28   10:15 - 11:15   1F   Room 4 (Ohwada-C)

Chair:

Akio Morinobu

Department of Rheumatology and Clinical Immunology, Graduate School of Medicine, Kyoto University, Japan

Speaker:

Roy M. Fleischmann

University of Texas Southwestern Medical Center at Dallas, Dallas, Texas, USA / Metroplex Clinical Research Center, USA

Sponsor:
AbbVie GK

LS14

SSc-ILD up to date

Wednesday, April 28   12:45 - 13:45   1F   Room 3 (Ohwada-B)

Chair:

Yasushi Kawaguchi

Department of Rheumatology, Tokyo Women's Medical University, Japan

LS14-1
Diagnosis and management of SSc-ILD
Speaker:

Yasushi Kawaguchi

Department of Rheumatology, Tokyo Women's Medical University, Japan

LS14-2
Management of SSc-ILD- role of immunomodulatory and antifibrotic therapies
Speaker:

Dinesh Khanna

University of Michigan, Ann Arbor, USA

Sponsor:
Nippon Boehringer Ingelheim Co., Ltd.

LS15

Strategy for management of RA: updated evidence from JAK inhibitors

Wednesday, April 28   12:45 - 13:45   1F   Room 4 (Ohwada-C)

Chair:

Tsutomu Takeuchi

Department of Internal Medicine, Division of Rheumatology, Keio University School of Medicine, Japan

LS15-1
Strategy for management of RA: Updated evidence from JAK
Speaker:

Ulf Müller-Ladner

Department of Rheumatology and Clinical Immunology, Justus-Liebig University Giessen, Campus Kerckhoff, Bad Nauheim, Germany

LS15-2
To achieve target of treating RA
Speaker:

Tatsuya Atsumi

Department of Rheumatology, Endocrinology and Nephrology, Faculty of Medicine, Hokkaido University, Japan

Sponsor:
Eli Lilly Japan K.K.

AS1

Simplifying RA management and preventing structural joint damage with filgotinib, a once-daily oral JAK inhibitor

Monday, April 26   16:30 - 17:30   1F   Room 2 (Ohwada-A)

Chair:

Tsutomu Takeuchi

Department of Internal Medicine Division of Rheumatology, Keio University School of Medicine, Japan

Speaker:

Paul Emery

Versus Arthritis Professor of Rheumatology, Leeds Institute Rheumatic and Musculoskeletal Medicine University Leeds
Director Leeds NIHR Biomedical Research Centre, The Leeds Teaching Hospitals Trust, Leeds UK

Sponsor:
Gilead Sciences K.K. / Eisai Co., Ltd.

AS2

New insights for basic and clinical practice in SpA

Monday, April 26   16:30 - 18:00   1F   Room 3 (Ohwada-B)

Chair:

Michiaki Takagi

Department of Orthopaedic, Yamagata University Faculty of Medicine, Japan

AS2-1
Regulatory mechanism of bone remodeling by cytokines
Speaker:

Tomoki Nakashima

Department of Cell Signaling, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Japan

AS2-2
New Insights for Clinical Practice in SpA
Speaker:

Denis Poddubnyy

Rheumatology, Charité - Universitätsmedizin Berlin, Berlin, Germany

Sponsor:
Novartis Pharma K.K.

AS3

Role of IL-6 in rheumatoid arthritis

Monday, April 26   16:30 - 18:00   1F   Room 4 (Ohwada-C)

Chair:

Kei Ikeda

Department of Allergy and Clinical Immunology, Chiba University Hospital, Japan

AS3-1
Structure and functions of IL-6/IL-6 receptor and their pathophysiological roles in inflammatory conditions
Speaker:

Kei Ikeda

Department of Allergy and Clinical Immunology, Chiba University Hospital, Japan

AS3-2
The Role of IL-6 in Rheumatoid Arthritis
Speaker:

Allan Gibofsky

Weill Cornell Medicine, Clinic for Inflammatory Arthritis, Hospital for Special Surgery, New York, USA

Sponsor:
Asahi Kasei Pharma Corporation

AS12

Meet with Prof. Paul Emery -Potential of Filgotinib Considered from Global RATreatment, Guidelines and Clinical Trials-

Tuesday, April 27   16:30 - 17:30   B1F   Room 7 (Kairaku-3)

Chair:

Hiroaki Niiro

Department of Medical Education, Faculty of Medical Sciences, Kyushu University, Japan

Speaker:

Paul Emery

Versus Arthritis Professor of Rheumatology, Leeds Institute Rheumatic and Musculoskeletal Medicine University Leeds
Director Leeds NIHR Biomedical Research Centre, The Leeds Teaching Hospitals Trust, Leeds UK

Discassants:

Kosuke Ebina

Department of Musculoskeletal Regenerative Medicine, Osaka University Graduate School of Medicine, Japan

Masaru Kato

Department of Rheumatology, Endocrinology and Nephrology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Japan

Shingo Nakayamada

The First Department of Internal Medicine, University of Occupational and Environmental Health, Japan

Hironari Hanaoka

Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Japan

Sponsor:
Gilead Sciences K.K. / Eisai Co., Ltd.

ES1

Targeting of the IL-6 pathway for treatment of rheumatoid arthritis: past, present and future

Monday, April 26   18:15 - 19:45   1F   Room 2 (Ohwada-A)

Chairs:

Masataka Kuwana

Department of Allergy and Rheumatology, Nippon Medical School Graduate School of Medicine, Japan

 

Kunihiro Yamaoka

Department of Rheumatology and Infectious Diseases, Kitasato University School of Medicine, Japan

ES1-1
Interleukin-6 as a key driver linking inflammation and structural bone changes in arthritis
Speaker:

Georg Schett

Department of Internal Medicine 3 Rheumatology and Immunology, Friedrich Alexander University, Erlangen-Nurnberg, Germany

ES1-2
Perspectives on tocilizumab
Speaker:

Yoshiya Tanaka

The First Department of Internal Medicine, School of Medicine, University of Occupational & Environmental Health, Japan

Sponsor:
Chugai Pharmaceutical Co., Ltd.

International Concurrent Workshop (On demand (Slides with audio))

On demand period: April 28 (Wed.), 17:00 - May 31 (Mon.), 12:00, Japan Standard Time (GMT+9)

  • Japan College of Rheumatology
  • APLAR2021

PAGE TOP